621. [ALS disease modeling using patient - specific iPS cells].622. [Disease modeling using induced pluripotent stem cells (general remarks)].623. [iPS-cell research using swine].624. [Development of novel techniques for quality evaluation of processed cells for regenerative medicine derived from iPS cells or from somatic stem cells].625. [Development of iPS cell culture platform for regenerative medicine].626. [Development of culture substrates for pluripotent stem cells].627. [Establishment of directed differentiation systems by manipulating transcription factors in pluripotent stem cells].
作者: Tomohiko Akiyama.;Yuhki Nakatake.;Kohei Yamamizu.;Atsumi Soma.;Shigeru Ko.;Minoru Ko.
来源: Nihon Rinsho. 2015年73 Suppl 5卷330-6页 628. [Development of mucosal regenerative therapies for inflammatory bowel diseases using cultured intestinal epithelial stem cells].629. [Novel therapy for severe heart failure using iPS - derived cardiomyocytes transplantation].630. [The development of myocardial regeneration therapy using cell sheet technology and iPS cells].631. [Regeneration of the injured spinal cord via activation of endogenous neural stem].632. [Regenerative medicine approach using stem cell based organ graft package].633. [Stem cells in the hair follicle].634. [Intestinal stem cells].
作者: Yoshihiro Nakazato.;Shinya Sugimoto.;Kosaku Nanki.;Toshiro Sato.
来源: Nihon Rinsho. 2015年73 Suppl 5卷232-7页 635. [Biokinetics of mesenchymal stem cells].636. [Hematopoietic stem cells].637. [Adult neural stem cells].638. [Molecular mechanism underlying the cytogenesis from neural stem/progenitor cells].639. [Neural crest stem cells: road to regenerative medicine for damaged central nervous system].640. [Cell type conversion to chondrocytes through direct reprogramming or iPS cells]. |